Discover our latest news, updates and press releases

Univercells S.A. (“Univercells”) and Unizima S.A. (“the Company”), announce today the appointment of Hala Audi as Chief Executive Officer of Unizima, a Univercells Company dedicated to delivering facilities, services and expertise to meet local demand for biologics in low-to-middle-income countries. Hala’s appointment will bring the Company to its next level, driven by its mission of […]

An innovative new partnership was announced today to revolutionize access to COVID-19 and other vaccines in Africa by manufacturing these vaccines at the Institut Pasteur de Dakar (IPD) as part of the project known as MADIBA, “Vaccines in Africa, for Africa”. The partnership will see Unizima, a Univercells company, Intact and KeyPlants collaborate with the […]

• €30 million loan agreement for a new COVID-19 vaccine manufacturing facility in Wallonia (Belgium) and for the co-development of a pipeline of COVID-19 vaccines. • Part of the EIB’s COVID-19 response, the partnership aims to support Univercells’s contribution to the fight against the COVID-19 pandemic while creating significant long term value and impact globally. […]

Brussels, Belgium, June 30, 2021 Univercells S.A. (the “Company”) announces a rebranding of its visual identity and update of its mission to reflect the evolution of the Company over the years. Coinciding with the unveiling of its new identity, Univercells launches a new corporate website (www.univercells.com) focusing on the Group’s vision, mission, and ambition. “The […]

Univercells S.A. (“Univercells”) and Exothera S.A. (the “Company”) are pleased to announce that effective June 1, 2021, Thibault Jonckheere has been appointed as Chief Executive Officer of Exothera, a Univercells company and uniquely positioned full-service viral vector Contract Development and Manufacturing Organization (CDMO). The appointment of Thibault is the next step in driving Exothera to […]

Partnership will leverage companies’ core technologies in vaccine development and viral vaccine manufacturing Codagenix Inc., a clinical-stage biotechnology company developing prophylactic vaccines and oncolytic virus therapies, and Univercells S.A., a global life sciences company using bioprocessing expertise and nextgeneration technologies to open access to bioproduction, today announced a research collaboration agreement on an undisclosed, high-priority […]

Minister-President of Wallonia, Elio Di Rupo has the honor of welcoming today His Excellency, Macky Sall, President of Senegal and prominent Senegalese institutions in public health to meet with Univercells and advance collaborations in line with Senegal’s scientific development and public health goals, bolstering Senegal’s public health ambitions. Accompanying the Senegalese Political Delegation to meet […]

Mathias Garny has been appointed as the Chief Executive Officer of Univercells Technologies, a Univercells company and global provider of next-generation bioprocess technologies. Univercells S.A. (“Univercells”), Univercells Technologies (the “Company”), and Gamma Biosciences (“Gamma”) are pleased to announce that effective March 15, 2021, Mathias Garny has been appointed as the Chief Executive Officer of Univercells […]